Previous Close | 1.3500 |
Open | 1.3500 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 1.3250 - 1.4500 |
52 Week Range | 0.9100 - 2.4000 |
Volume | |
Avg. Volume | 22,418 |
Market Cap | 16.987M |
Beta (5Y Monthly) | 0.78 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.6300 |
Earnings Date | Nov 22, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for PBIO
MIAMI, March 21, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 52nd Emerging Growth Conference on March 22, 2023. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the conference here. Submit Questions for any of the presenting companies
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences and other industries, today announced that the Company's largest shareholder has exchanged over $10 million of senior secured debt into unsecured preferred stock.
By Rachael Green, Benzinga